Johnson & Johnson Sunscreen Recall Announced Due to Cancer Concerns

Between the nice weather and relaxed Covid-19 restrictions, many of us have been taking the opportunity to get outside and…

Read More

Paraquat Exposure Linked to Parkinson’s Disease – What You Need to Know

As one of the world’s largest agricultural producing countries, the U.S. is known for using some of the most advanced…

Read More

FDA Issues Safety Advisory Against Stryker STAR Ankle Devices

On Monday, March 15, 2021, The U.S. Food and Drug Administration (FDA) issued a safety advisory to patients and health…

Read More

Protecting Your Genetic Information: The New Frontier of Data Privacy

An important new law took effect in Illinois on January 1, 2020 – no, not that one. This law, rather,…

Read More

FDA Warns of Cancer-Causing Substance in Heartburn Drug Zantac

With thousands of drugs available to consumers, both by prescription and over-the-counter, it should surprise no one that a large…

Read More

Justice Department Investigating Johnson & Johnson for Concealing Talcum Powder Cancer Risks

The possible link between Johnson & Johnson Baby Powder and ovarian cancer has been the subject of numerous health studies,…

Read More

Juul E-Cigarettes Leave a Cloud of Addiction and Potential Health Risks

 

According to Juul Labs, makers of the most popular e-cigarette on the market, Juul devices were developed to provide adult…

Read More

Is it Time for New U.S. Data Privacy Laws?

“If you’re not paying for the product, you are the product.” While this phrase actually pre-dates the internet, it has…

Read More

FDA Investigates Potential Link between Vaping and Seizures

The Food and Drug Administration has reviewed 35 reports of seizures among e-cigarette users, mainly young people. The FDA is…

Read More

Fisher-Price Rock ‘n Play Sleeper Linked to Numerous Infant Deaths

 

Update 4/12/19: Fisher-Price has announced a voluntary recall of 4.7 million Rock ‘n Play sleepers. Click here for more information…

Read More

Sign Up For Our Newsletter

Stay informed with Wexler Wallace